{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:51:52Z","timestamp":1791219112275,"version":"4.1.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Mycetoma is a neglected tropical disease commonly caused by the fungus Madurella mycetomatis. Standard treatment consists of extensive treatment with itraconazole in combination with surgical excision of the infected tissue, but has a low success rate. To improve treatment outcomes, novel treatment strategies are needed. Here, we determined the potential of manogepix, a novel antifungal agent that targets the GPI-anchor biosynthesis pathway by inhibition of the GWT1 enzyme. Manogepix was evaluated by determining the minimal inhibitory concentrations (MICs) according to the CLSI-based in vitro susceptibility assay for 22\u00a0M. mycetomatis strains and by in silico protein comparison of the target protein. The synergy between manogepix and itraconazole was determined using a checkerboard assay. The efficacy of clinically relevant dosages was assessed in an in vivo grain model in Galleria mellonella larvae. MICs for manogepix ranged from\u00a0&amp;lt;0.008 to &amp;gt;8\u00a0mg\/l and 16\/22\u00a0M. mycetomatis strains had an MIC \u22654\u00a0mg\/ml. Differences in MICs were not related to differences observed in the GWT1 protein sequence. For 70% of the tested isolates, synergism was found between manogepix and itraconazole in vitro. In vivo, enhanced survival was not observed upon admission of 8.6\u00a0mg\/kg manogepix, nor in combination treatment with 5.7\u00a0mg\/kg itraconazole. MICs of manogepix were high, but the in vitro antifungal activity of itraconazole was enhanced in combination therapy. However, no efficacy of manogepix was found in an in vivo grain model using clinically relevant dosages. Therefore, the therapeutic potential of manogepix in mycetoma caused by M. mycetomatis seems limited.<\/jats:p>","DOI":"10.1093\/mmy\/myad118","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T07:50:33Z","timestamp":1699948233000},"source":"Crossref","is-referenced-by-count":8,"title":["The combination of manogepix and itraconazole is synergistic and inhibits the growth of <i>Madurella mycetomatis in vitro<\/i> but not <i>in vivo<\/i>"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3983-4304","authenticated-orcid":false,"given":"Mickey","family":"Konings","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, ErasmusMC University Medical Center Rotterdam , Dr. Molewaterplein 40, 3015GD, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Eadie","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, ErasmusMC University Medical Center Rotterdam , Dr. Molewaterplein 40, 3015GD, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0997-8430","authenticated-orcid":false,"given":"Nikolaos","family":"Strepis","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, ErasmusMC University Medical Center Rotterdam , Dr. Molewaterplein 40, 3015GD, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1454-6149","authenticated-orcid":false,"given":"Bertrand","family":"Nyuykonge","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, ErasmusMC University Medical Center Rotterdam , Dr. Molewaterplein 40, 3015GD, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4922-7321","authenticated-orcid":false,"given":"Ahmed H","family":"Fahal","sequence":"additional","affiliation":[{"name":"Mycetoma Research Center, University of Khartoum , Khartoum , Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2242-8342","authenticated-orcid":false,"given":"Annelies","family":"Verbon","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, ErasmusMC University Medical Center Rotterdam , Dr. Molewaterplein 40, 3015GD, Rotterdam , The Netherlands"},{"name":"Department of Internal Medicine, UMC Utrecht , Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8652-8783","authenticated-orcid":false,"given":"Wendy W J","family":"van\u00a0de\u00a0Sande","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infectious Diseases, ErasmusMC University Medical Center Rotterdam , Dr. Molewaterplein 40, 3015GD, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"2023112820350415700_bib1","article-title":"Sixty-Ninth World Health Assembly - addressing the burden of mycetoma","author":"World Health Organization"},{"key":"2023112820350415700_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1473-3099(15)00359-X","article-title":"Mycetoma: a unique neglected tropical disease","volume":"16","author":"Zijlstra","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2023112820350415700_bib3","doi-asserted-by":"crossref","first-page":"e2550","DOI":"10.1371\/journal.pntd.0002550","article-title":"Global burden of human mycetoma: a systematic review and meta-analysis","volume":"7","author":"van\u00a0de\u00a0Sande","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2023112820350415700_bib4","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/B978-012373944-5.00226-1","article-title":"Fungal infections, cutaneous","volume-title":"Encyclopedia of Microbiology","author":"Watts","year":"2009","edition":"3rd edn."},{"key":"2023112820350415700_bib5","first-page":"e00449","article-title":"Threats posed by the fungal Kingdom to humans, wildlife, and agriculture","volume-title":"MBio","author":"Matthew","year":"2020"},{"key":"2023112820350415700_bib6","doi-asserted-by":"crossref","first-page":"e2667","DOI":"10.1371\/journal.pntd.0002667","article-title":"The mycetoma knowledge gap: identification of research priorities","volume":"8","author":"van\u00a0de\u00a0Sande","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2023112820350415700_bib7","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2133.2005.06534.x","article-title":"Madurella mycetomatis mycetoma treated successfully with oral voriconazole","volume":"152","author":"Lacroix","year":"2005","journal-title":"Br J Dermatol"},{"key":"2023112820350415700_bib8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1590\/S0036-46652005000600006","article-title":"Posaconazole treatment of refractory eumycetoma and chromoblastomycosis","volume":"47","author":"Negroni","year":"2005","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"2023112820350415700_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-4632.2004.02392.x","article-title":"Clinical efficacy and safety of oral terbinafine in fungal mycetoma","volume":"45","author":"N\u2019Diaye","year":"2006","journal-title":"Int J Dermatol"},{"key":"2023112820350415700_bib10","volume-title":"Clinical Trial for a Better Treatment for Mycetoma Starts in Sudan","author":"DNDi","year":"2017"},{"key":"2023112820350415700_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.trstmh.2010.11.008","article-title":"The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis","volume":"105","author":"Fahal","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2023112820350415700_bib12","doi-asserted-by":"crossref","first-page":"e0004690","DOI":"10.1371\/journal.pntd.0004690","article-title":"The surgical treatment of mycetoma","volume":"10","author":"Suleiman","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2023112820350415700_bib13","article-title":"Open-label study of APX001 for treatment of patients with invasive mold infections caused by Aspergillus or rare molds (AEGIS)","author":"Pharmaceuticals"},{"key":"2023112820350415700_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jgar.2021.04.012","article-title":"Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018\u20132019)","volume":"26","author":"Pfaller","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"2023112820350415700_bib15","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1128\/AAC.00731-11","article-title":"E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis","volume":"56","author":"Nao-aki","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib16","doi-asserted-by":"crossref","first-page":"e00730","DOI":"10.1128\/AAC.00730-20","article-title":"In vitro activity of manogepix (APX001A) and comparators against contemporary molds: MEC comparison and preliminary experience with colorimetric MIC determination","volume":"64","author":"J\u00f8rgensen","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib17","first-page":"e00656","article-title":"Manogepix (APX001A) in vitro activity against Candida auris: head-to-head comparison of EUCAST and CLSI MICs","volume":"64","author":"Maiken\u00a0Cavling","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib18","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1128\/JCM.37.10.3175-3178.1999","article-title":"Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis","volume":"37","author":"Ahmed","year":"1999","journal-title":"J Clin Microbiol"},{"key":"2023112820350415700_bib19","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1128\/JCM.43.9.4349-4356.2005","article-title":"Genotyping of Madurella mycetomatis by selective amplification of restriction fragments (amplified fragment length polymorphism) and subtype correlation with geographical origin and lesion size","volume":"43","author":"van\u00a0de\u00a0Sande","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2023112820350415700_bib20","doi-asserted-by":"crossref","first-page":"e02331","DOI":"10.1128\/JCM.02331-20","article-title":"A short-tandem-repeat assay (MmySTR) for studying genetic variation in Madurella mycetomatis","volume":"59","author":"Nyuykonge","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2023112820350415700_bib21","doi-asserted-by":"crossref","first-page":"e00418","DOI":"10.1128\/genomeA.00418-16","article-title":"Genome sequence of Madurella mycetomatis mm55, isolated from a human mycetoma case in Sudan","volume":"4","author":"Smit","year":"2016","journal-title":"Genome Announc"},{"key":"2023112820350415700_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/bioinformatics\/10.2.189","article-title":"MEGA: molecular evolutionary genetics analysis software for microcomputers","volume":"10","author":"Kumar","year":"1994","journal-title":"Bioinformatics"},{"key":"2023112820350415700_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol Syst Biol"},{"key":"2023112820350415700_bib24","first-page":"e01338","article-title":"Development and validation of an in vitro resazurin-based susceptibility assay against Madurella mycetomatis","volume":"65","author":"Abd\u00a0Algaffar","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib25","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1128\/AAC.48.7.2742-2746.2004","article-title":"In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay","volume":"48","author":"Ahmed","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib26","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/jac\/dkaa102","article-title":"A multicentre study to optimize echinocandin susceptibility testing of Aspergillus species with the EUCAST methodology and a broth microdilution colorimetric method","volume":"75","author":"Meletiadis","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2023112820350415700_bib27","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1128\/AAC.04487-14","article-title":"In vitro interaction of currently used azoles with terbinafine against Madurella mycetomatis","volume":"59","author":"Ahmed","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/13693780410001731547","article-title":"Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models","volume":"43","author":"Meletiadis","year":"2005","journal-title":"Med Mycol"},{"key":"2023112820350415700_bib29","first-page":"696","article-title":"Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatis","volume-title":"Trop Med Int Health","author":"Eadie","year":"2017"},{"key":"2023112820350415700_bib30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/jof6040239","article-title":"Fosmanogepix: a review of the first-in-class broad spectrum agent for the treatment of invasive fungal infections","volume":"6","author":"Shaw","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2023112820350415700_bib31","doi-asserted-by":"crossref","first-page":"e00429","DOI":"10.1128\/AAC.00429-20","article-title":"Manogepix (APX001A) displays potent in vitro activity against human pathogenic yeast, but with an unexpected correlation to fluconazole MICs","volume":"64","author":"Arendrup","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib32","doi-asserted-by":"crossref","first-page":"e00840","DOI":"10.1128\/AAC.00840-19","article-title":"In vitro activity of APX001A (Manogepix) and comparator agents against 1,706 fungal isolates collected during an international surveillance program in 2017","volume":"63","author":"Pfaller","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib33","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1128\/AAC.00570-11","article-title":"In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. Determined by CLSI and EUCAST broth microdilution methods","volume":"55","author":"Pfaller","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/AAC.05414-11","article-title":"Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods","volume":"56","author":"Mariana","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib35","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/jac\/dkz022","article-title":"In vitro activity of APX001A against rare moulds using EUCAST and CLSI methodologies","volume":"74","author":"Rivero-Menendez","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2023112820350415700_bib36","doi-asserted-by":"crossref","first-page":"e0010159","DOI":"10.1371\/journal.pntd.0010159","article-title":"Screening the pandemic response box identified benzimidazole carbamates, olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma","volume":"16","author":"Lim","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"2023112820350415700_bib37","doi-asserted-by":"crossref","first-page":"e38654","DOI":"10.1371\/journal.pone.0038654","article-title":"Phylogenetic analysis of the complete mitochondrial genome of Madurella mycetomatis confirms its taxonomic position within the order Sordariales","volume":"7","author":"van\u00a0de\u00a0Sande","year":"2012","journal-title":"PLoS One"},{"key":"2023112820350415700_bib38","doi-asserted-by":"crossref","first-page":"e02343","DOI":"10.1128\/AAC.02343-20","article-title":"Manogepix, the active moiety of the investigational agent Fosmanogepix, demonstrates in vitro activity against members of the Fusarium oxysporum and Fusarium solani species complexes","volume":"65","author":"Badali","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib39","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/AAC.01546-09","article-title":"Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents","volume":"54","author":"van\u00a0de\u00a0Sande","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib40","doi-asserted-by":"crossref","first-page":"e00523","DOI":"10.1128\/AAC.00523-18","article-title":"In vitro and in vivo evaluation of APX001A\/APX001 and other Gwt1 inhibitors against Cryptococcus","volume":"62","author":"Shaw","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib41","article-title":"In vitro activity of E1210 and in vivo activity of E1211: a water-soluble prodrug of E1210, in combination with other antifungals","author":"Watanabe"},{"key":"2023112820350415700_bib42","doi-asserted-by":"crossref","first-page":"e02319","DOI":"10.1128\/AAC.02319-17","article-title":"In vitro and in vivo evaluation of the antifungal activity of APX001A\/APX001 against Candida auris","volume":"62","author":"Hager","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib43","doi-asserted-by":"crossref","first-page":"e01120","DOI":"10.1128\/AAC.01120-19","article-title":"Efficacy of delayed therapy with fosmanogepix (APX001) in a murine model of Candida auris invasive candidiasis","volume":"63","author":"Wiederhold","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib44","doi-asserted-by":"crossref","first-page":"e01713","DOI":"10.1128\/AAC.01713-18","article-title":"APX001 is effective in the treatment of murine invasive pulmonary aspergillosis","volume":"63","author":"Gebremariam","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib45","doi-asserted-by":"crossref","first-page":"e01735","DOI":"10.1128\/AAC.01735-19","article-title":"Fosmanogepix (APX001) is effective in the treatment of immunocompromised mice infected with invasive pulmonary scedosporiosis or disseminated fusariosis","volume":"64","author":"Alkhazraji","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib46","doi-asserted-by":"crossref","first-page":"e00178","DOI":"10.1128\/AAC.00178-20","article-title":"Fosmanogepix (APX001) is effective in the treatment of pulmonary murine mucormycosis due to Rhizopus arrhizus","volume":"64","author":"Gebremariam","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2023112820350415700_bib47","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1365-2958.2007.05709.x","article-title":"Glycosylphosphatidylinositol (GPI) anchor is required in Aspergillus fumigatus for morphogenesis and virulence","volume":"64","author":"Li","year":"2007","journal-title":"Mol Microbiol"},{"key":"2023112820350415700_bib48","doi-asserted-by":"crossref","first-page":"e0003926","DOI":"10.1371\/journal.pntd.0003926","article-title":"A Madurella mycetomatis grain model in Galleria mellonella larvae","volume":"9","author":"Kloezen","year":"2015","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myad118\/53381394\/myad118.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/61\/11\/myad118\/53897120\/myad118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/61\/11\/myad118\/53897120\/myad118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T20:35:46Z","timestamp":1701203746000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myad118\/7419863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,6]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myad118","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,11]]},"article-number":"myad118"}}